Trendlines slips below the line on debut
Singapore
THE trading debut of Trendlines Group, an Israeli biomed incubator, on the Catalist board may be worthy of celebration for several reasons but its shabby stock performance on Thursday belied that.
Trendlines is the 100th firm to seek a new listing on Catalist since the junior board was launched eight years ago and it also marks the first listing of an Israeli firm on SGX in a decade.
TRENDING NOW
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
Cat A COE rate exceeds Cat B for third time in 4 months; premiums largely down
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
Singapore workers experiencing rising anxiety; signs of fallout from pressure to use AI